rPA-7909

N/A

Report date: 2026/04/07 14:22:46

Base Information

Drug NamerPA-7909
Drug Alias Nameanthrax vaccine (recombinant protective antigen + CpG-7909) (Emergent BioSolutions)rPA-7909rPA7909
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsAnthrax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmergent Biosolutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions Inc
Inactive CompaniesN/A
Active IndicationsAnthrax
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A